Martin Shkreli

	A	B	C	D	E	F	G	H	I	J	K	L	M	N	W	X	Y	Z	AA	AB	AC	AD	AE	AF	AG	AH	AI	AJ	AK	AL
1	Main
2			Q120	Q220	Q320	Q420	Q121	Q221	Q321	Q421	Q122	Q222	Q322	Q422	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030
3		Brands				1859	2724.6	2701.7	2803.1	2611.9	2554.1	2483.1	2540.3
4		Complex/BS				338.8	328.9	332.8	332	348.4	390.8	354.8	320.2
5		Generics				1389.9	1346.6	1527.2	1385.4	1371	1233.3	1267.5	1206.9
6
7		Developed				2378.6	2571.6	2640.4	2655.9	2560.8	2476.1	2479.1	2431.5								10428.7	9768.9
8		China				190.6	591.9	550.3	792.5	503.8	573.1	548.3	678.9								2212.8	2201.2
9		JANZ				389.5	481.9	501	505.3	539.2	423.8	427.1	383								2027.4	1632.4
10		Emerging				629	754.7	870	566.8	727.5	705.2	650.9	574								3144.7	2615.6
11
12		Lipitor					464.6	398.3	410	390.3	440.1	405.6	420.4
13		Norvasc					227.7	209.8	198.4	188.8	207.8	203	189.3
14		Lyrica					187.8	192.5	175.6	172.6	171.7	155.8	156.5
15		Viagra					139.6	134.8	138	121.4	129.8	115.1	117
16		EpiPen					103.7	104.1	129.5	54.4	88.8	106.5	114.4
17		Celebrex					89	82.3	86	87.1	85.2	85.9	82.2
18		Creon					69.9	80.7	81.1	78.1	74.7	75.4	76.4
19		Effexor					76.6	83.5	79.5	77.2	77.5	73.7	64.2
20		Zoloft					76.6	70.9	61.3	75.5	73.1	62.5	53.1
21		Xala					57.9	58.3	55.8	54	53	42.7	51
22		Influvac							161.2	134			159.3
23		Dymista					40.3	54.6	35	38.1	44	55.5	38.6
24		Yupelri					36.9	41.8	39.4	43.8	43.7	49.1	53.4
25		Amitiza					45.9	52.1	49.5	54	41.8	44.1	39.4
26		Xanax					45.1	48.8	47.6	44.4	40	37.2	38.3
27
28		Product				3587.7	4400.1	4561.7	4520.5	4331.3	4178.2	4105.4	4067.4							11819.9	17813.6	16218.099999999999
29		Other				35.8	30.2	16.1	16.1	10.3	13.5	11.4	10.8							126.1	72.7	44.6
30		Revenue				3623.5	4430.3	4577.8	4536.6	4341.6	4191.7	4116.799999999999	4078.2000000000003							11946	17886.3	16262.699999999999
31		COGS				2917.1	3303	3250.1	2962.5	2795.2	2420.5	2413.5	2329.8							8149.3	12310.8	9765.7
32		Gross Profit				706.4000000000001	1127.3000000000002	1327.7000000000003	1574.1000000000004	1546.4000000000005	1771.1999999999998	1703.2999999999993	1748.4							3796.7	5575.5	6496.999999999998
33		R&D				154.8	184.1	147.7	152.1	267.2	142.3	162.6	174.9							512.6	681	662.2
34		SG&A				1361.4	1186.5	1204.8	1055	1082.9	915.3	981.1	1017.3							3344.6	4529.2	4179.1
35		OpEx				1516.2	1370.6	1352.5	1207.1	1350.1000000000001	1057.6	1143.7	1192.2							3857.2	5210.2	4841.3
36		OpInc				-809.8	-243.29999999999973	-24.799999999999727	367.00000000000045	196.3000000000004	713.5999999999999	559.5999999999992	556.2							-60.5	365.3000000000002	1655.699999999998
37		Interest				-132.4	-175.1	-171.29999999999998	-157.70000000000002	-126.29999999999998	-179.89999999999998	-159.4	-132.6							-497.8	-636.2	-592.4
38		Pretax				-942.1999999999999	-418.39999999999975	-196.0999999999997	209.30000000000044	70.00000000000043	533.6999999999999	400.19999999999925	423.6							-558.3	-270.89999999999986	1063.299999999998
39		Taxes				0	596.3	60.1	0	59.9	128.3	75.4	73.2							0	0	734.6
40		Net Income				-942.1999999999999	-1014.6999999999997	-256.1999999999997	209.30000000000044	10.100000000000428	405.3999999999999	324.7999999999993	350.40000000000003							-558.3	-270.89999999999986	328.6999999999979
41		EPS				-1.1027621722846441	-0.8403312629399583	-0.2119457313037721	0.1726043212930896	0.00835124855300184	0.3341851454950127	0.266863856708569	0.28766111156719487							-0.9286427145708581	-0.22410655195234933	0.2700016428454065
42		Shares				854.4	1207.5	1208.8	1212.6	1209.4	1213.1	1217.1	1218.1							601.2	1208.8	1217.4
43
44
45		Revenue y/y								0.19817855664412876	-0.053856397986592364	-0.10070339464371547	-0.1010448353392408								0.4972626820693118	-0.09077338521661837
46		Gross Margin				0.19494963433144752	0.254452294427014	0.2900301454847307	0.34697791297447433	0.35618205269946573	0.42254932366343007	0.4137436844150796	0.4287185523024864							0.3178218650594341	0.31171902517569317	0.399503157532267
47
48		Net Cash																				-18014.399999999998
49		Cash									752.4	664.7	646.7									1259.9
50		AR									4093.9	3736.2	3333.9									3814.5
51		Inventories									3797.3	3612.5	3380.4									3519.5
52		Prepaid									1763.6	1697.7	1700.4									1811.2
53		Held for Sale									1337.1	1465.4	1426.4									230.3
54		PP&E									3150.2	3083.9	3039									3024.5
55		Goodwill									36230.6	34624.1	33067.9									33032.899999999994
56		Taxes									1285.8	1243.2	1104									925.9
57		OA									1056	997.4	963.9									2403.5
58		Assets									53466.9	51125.1	48662.6									50022.2
59
60		AP									1499.6	1670.1	1310.5									1766.6
61		Debt									22024	20994.300000000003	19988.7									19274.3
62		Taxes									2907.3	2743.6	2596									2711.6
63		Held for Sale									277.7	285.1	335.3									0
64		OCL									4426.3	3812.4	3504.7									3440.9
65		ONCL									1884.3	1814.2	1745.1									1756.5
66		Liabilities																				28949.899999999998
67		SE (Book Value)									20447.7	19805.4	19182.3									21072.3
68		L+SE									53466.899999999994	51125.100000000006	48662.6									50022.2
69
70		Book Value																				21072.3
71		Tangible Book Value																				-11960.599999999995
72
73		Model NI									405.3999999999999	324.7999999999993
74		Reported NI									399.2	313.90000000000003
75		D&A									736	722.3
76		SBC									28.3	29.400000000000002
77		DT									-52.8	-104.8
78		Equity									-0.1	0.1
79		Other									37.8	-34
80		Litigation									5.2	4.8
81		WC									-15.099999999999994	-129.20000000000002
82		CFFO									1138.5000000000002	802.5000000000001
83
84		CapEx									-64.5	-83.9
85		Securities									-0.09999999999999964	-0.29999999999999893
86		Product Rights									-7.4	-5.6
87		Sale of Assets									5.1	7.700000000000001
88		CFFI									-66.9	-82.1
89
90		Debt & Other									-838.5	-627.3999999999999
91		SBC Taxes									-9.9	-3.299999999999999
92		CoCo									-15.5	-3.3999999999999986
93		Dividends									-145.1	-145.50000000000003
94		CFFF									-1009	-779.5999999999998
95		FX									-11.4	-28.800000000000004
96		CIC									51.20000000000027	-87.99999999999966